Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: the PIONEER programme

Citation
Thethi TK, Pratley R, Meier JJ. Diabetes Obes Metab 2020; epub ahead of press.